We aimed to assess the relationship of the angiogenic cytokines VEGF-A, VEG
F-C, and VEGF-D and their receptors VEGFR-2 and VEGFR-3 in the adenoma-carc
inoma sequence and in metastatic spread of colorectal cancer (CRC). mRNA ex
pression levels were measured using semi-quantitative reverse transcription
polymerase chain reaction in 70 CRC (35 with paired mucosae) and 20 adenom
atous polyps. Immuohistochemistry and ELISA assessed protein expression. VE
GF-D mRNA expression was significantly lower in both polyps and CRCs compar
ed with normal mucosa (P=.0002 and .002, respectively), whereas VEGF-A and
VEGF-C were significantly raised in CRCs (P=.006 and .004, respectively), b
ut not polyps (P=.22 and P=.5, respectively). Receptor expression was simil
ar in tumor tissue and normal mucosae. Tumors with lymph node metastases ha
d significantly higher levels of VEGF-A compared with non-metastatic tumors
(P=.043). There was no association between VEGF-C or VEGF-D and lymphatic
spread. The decrease in VEGF-D occurring in polyps and carcinomas may allow
the higher levels of VEGF-A and VEGF-C to bind more readily to the VEGF re
ceptors, and produce the angiogenic switch required for tumor growth. Incre
ased expression of VEGF-A within CRCs was associated with lymphatic metasta
ses, and therefore, this member of the VEGF family may be the most importan
t in determining metastatic spread.